As of June 30, 2026, PT Lotte Chemical Titan Tbk carries a market capitalization of 1.76T, placing it among publicly traded companies globally. Its enterprise value stands at 1.13T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.76T |
| Enterprise Value | 1.13T |
As of June 30, 2026, PT Lotte Chemical Titan Tbk has 5.57B shares outstanding.
| Shares Outstanding | 5.57B |
As of June 30, 2026, PT Lotte Chemical Titan Tbk trades at a trailing price-to-earnings ratio of 5.92. The price-to-sales ratio is 0.28, and the price-to-book ratio stands at 0.88.
| PE Ratio | 5.92 |
| PS Ratio | 0.28 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.88 |
As of June 30, 2026, PT Lotte Chemical Titan Tbk trades at an EV/EBITDA multiple of 8.00 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.18 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 8.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.13T versus a market cap of 1.76T, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.18 |
| EV / EBITDA | 8.00 |
| EV / EBIT | 8.40 |
As of June 30, 2026, PT Lotte Chemical Titan Tbk maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.13, indicating conservative leverage, while an interest coverage ratio of 112.56 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.53 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 112.56 |
Over the twelve months ended June 30, 2026, PT Lotte Chemical Titan Tbk posted a return on equity (ROE) of 16.11, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.51 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 16.08, useful for judging operating efficiency across full business cycles. The company generates approximately 19.15B in revenue per employee across its workforce of 322.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 8.81 indicates how many times PT Lotte Chemical Titan Tbk sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 16.11 |
| Return on Assets (ROA) | 10.55 |
| Return on Invested Capital (ROIC) | 6.51 |
| Return on Capital Employed (ROCE) | 16.08 |
| Revenue Per Employee | 19.15B |
| Employee Count | 322.50 |
| Inventory Turnover | 8.81 |
Over the twelve months ended June 30, 2026, PT Lotte Chemical Titan Tbk recorded 34.08B in income tax expense. That works out to an effective tax rate of 10.27, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 331.88B, leaving 297.35B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 34.08B |
| Effective Tax Rate | 10.27 |
As of the close on October 22, 2026, PT Lotte Chemical Titan Tbk's stock has gained approximately 118.75% over the past 52 weeks. The 50-day moving average sits at 521.58, while the 200-day moving average is 504.75.
| 52-Week Price Change | 118.75% |
| 50-Day Moving Average | 521.58 |
| 200-Day Moving Average | 504.75 |
Over the twelve months ended June 30, 2026, PT Lotte Chemical Titan Tbk generated 6.18T in revenue and converted that into 297.35B in net income, yielding earnings per share of 53.50. EBITDA reached 141.48B, while operating income came in at 134.80B.
| Revenue | 6.18T |
| Gross Profit | 315.24B |
| Operating Income | 134.80B |
| Pretax Income | 331.88B |
| Net Income | 297.35B |
| EBITDA | 141.48B |
| EBIT | 134.80B |
| Earnings Per Share (EPS) | 53.50 |
As of June 30, 2026, PT Lotte Chemical Titan Tbk holds 632.00B in cash and equivalents against 2.64B in total debt, resulting in a net debt position of -519.94B. Total book value stands at 1.99T, with working capital of 622.80B providing operational flexibility.
| Cash & Cash Equivalents | 632.00B |
| Total Debt | 2.64B |
| Net Debt | -519.94B |
| Equity (Book Value) | 1.99T |
| Book Value Per Share | 357.81 |
| Working Capital | 622.80B |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -55.74B |
Over the twelve months ended June 30, 2026, PT Lotte Chemical Titan Tbk posted a gross margin of 5.10, reflecting its pricing power and cost economics. The operating margin of 2.18 and net profit margin of 4.81 provide insight into operational efficiency.
| Gross Margin | 5.10 |
| Operating Margin | 2.18 |
| Pretax Margin | 5.37 |
| Profit Margin | 4.81 |
| EBITDA Margin | 2.29 |
These figures cover the twelve months ended June 30, 2026. Total shareholder yield reaches 0.51, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to PT Lotte Chemical Titan Tbk shareholders.
| Shareholder Yield | 0.51 |
PT Lotte Chemical Titan Tbk's most recent stock split took place on December 26, 2007 with a 474:647 split ratio.
| Last Split Date | 12/26/2007 |
| Split Ratio | 474:647 |
As of June 30, 2026, PT Lotte Chemical Titan Tbk has an Altman Z-Score of 2.33, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.33 |
Already premium?